Changeflow GovPing Pharma & Drug Safety EPO Patent Application for Antimicrobial Peptoi...
Routine Notice Added Final

EPO Patent Application for Antimicrobial Peptoid Copolymers

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Peptides (C07K)
Published March 11th, 2026
Detected March 26th, 2026
Email

Summary

The European Patent Office (EPO) has published a patent application (EP4294821A1) for antimicrobial cationic peptoid and N-substituted peptidic copolymers, their preparation, and uses. The application was filed on March 11, 2026, by UNIVERSITE DE BORDEAUX and other research institutions.

What changed

This document is a publication of a European patent application (EP4294821A1) concerning antimicrobial cationic peptoid and N-substituted peptidic copolymers. The application, filed on March 11, 2026, details the preparation and uses of these novel materials. The applicants include UNIVERSITE DE BORDEAUX, Centre National de la Recherche Scientifique, Institut Polytechnique de Bordeaux, Université Paul Sabatier Toulouse III, and Institut Pasteur.

As this is a patent application publication, it does not impose direct compliance obligations on regulated entities. However, it signifies potential future developments in antimicrobial technologies. Companies in the pharmaceutical, biotechnology, and medical device sectors may wish to monitor the progress of this patent application and related research for potential licensing opportunities or competitive intelligence.

Source document (simplified)

← EPO Patent Bulletin

ANTIMICROBIAL CATIONIC PEPTOID AND N-SUBTITUTED PEPTIDIC COPOLYMERS, PREPARATION AND USES THEREOF

Publication EP4294821A1 Kind: A1 Mar 11, 2026

Applicants

UNIVERSITE DE BORDEAUX, Centre National de la Recherche Scientifique, Institut Polytechnique de Bordeaux, Université Paul Sabatier Toulouse III, Institut Pasteur

Inventors

BONDUELLE, Colin, VERHAEGHE, Pierre, DUPUY, Bruno, SALAS-AMBROSIO, Pedro, TRONNET, Antoine

IPC Classifications

C07K 14/00 20060101AFI20220826BHEP A61K 47/00 20060101ALI20220826BHEP A61P 31/04 20060101ALI20220826BHEP A61K 38/00 20060101ALI20220826BHEP A61L 27/00 20060101ALI20220826BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

ANTIMICROBIAL CATIONIC PEPTOID AND N-SUBSTITUTED PEPTIDIC COPOLYMERS, PREPARATION AND USES THEREOF

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 11th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP4294821A1

Who this affects

Applies to
Drug manufacturers Medical device makers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Activity scope
Drug Development Medical Device Innovation
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Research & Development
Topics
Medical Devices Public Health

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Peptides (C07K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.